McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why

McKesson (MCK) is identified as a strong growth stock based on its favorable Zacks Growth Style Score of A and a Zacks Rank #2 (Buy). The company's EPS is projected to grow 12.5% this year, significantly exceeding the industry average of 8.2%, and sales are expected to increase by 13% compared to the industry average of 3.2%. Additionally, McKesson's current-year earnings estimates have been revised upward, with the Zacks Consensus Estimate increasing by 1.7% over the past month, further solidifying its potential for near-term stock price appreciation.

Analysis

McKesson Corporation (MCK) presents a compelling growth narrative, underscored by a Zacks Growth Style Score of A and a Zacks Rank #2 (Buy). The company's earnings outlook is robust, with projected EPS growth of 12.5% for the current year, significantly outpacing the industry average of 8.2%. This forward-looking projection is supported by a historical EPS growth rate of 16%. Furthermore, McKesson demonstrates superior asset utilization, evidenced by a sales-to-total-assets (S/TA) ratio of 4.95, which indicates it generates $4.95 in sales for each dollar of assets, far exceeding the industry benchmark of 0.77. This efficiency is complemented by strong top-line expectations, as company sales are forecast to grow 13% this year, compared to an industry average of 3.2%. Reinforcing this positive outlook, current-year earnings estimates for McKesson have seen upward revisions, with the Zacks Consensus Estimate increasing by 1.7% over the past month, a factor empirically correlated with near-term stock price appreciation. The combination of these strong fundamental metrics positions MCK favorably within the prescription drug distribution sector.

Key Decisions for Investors

• Investors seeking growth opportunities may find McKesson an attractive candidate, given its strong earnings and sales growth projections, superior asset efficiency, and positive earnings estimate revisions.
• Consider initiating or adding to positions in MCK, particularly for portfolios with a growth-focused mandate, while acknowledging the inherent higher risk and volatility typically associated with growth stocks.
• Monitor upcoming earnings reports and analyst estimate revisions closely to ensure the company maintains its growth trajectory and operational efficiency as projected.